Showing results (311-320 of 463) with videos related to

Sort By:
Pageof 47
Clinical and Experimental Rheumatology|April 20, 2017
Microscopic polyangiitis and non-HBV polyarteritis nodosa with poor-prognosis factors: 10-year results of the prospective CHUSPAN trialMaxime Samson, Xavier Puéchal, Luc Mouthon, et al.
American Journal of Ophthalmology|July 20, 2019
Glucocorticoid Receptor-α and MKP-1 as Candidate Biomarkers for Treatment Response and Disease Activity in Vogt-Koyanagi-Harada DiseaseCristhian A Urzua, Ping Chen, Benjamin Chaigne-Delalande, et al.
Diagnostics (Basel, Switzerland)|May 28, 2022
Autoantibodies versus Skin Fibrosis Extent in Systemic Sclerosis: A Case-Control Study of Inverted PhenotypesAshley Tieu, Benjamin Chaigne, Bertrand Dunogué, et al.
Annals of Internal Medicine|November 3, 2005
Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndromeRégis Sablé-Fourtassou, Pascal Cohen, Alfred Mahr, et al.
Neuromuscular Disorders : NMD|April 18, 2006
Marked efficacy of a therapeutic strategy associating prednisone and plasma exchange followed by rituximab in two patients with refractory myopathy associated with antibodies to the signal recognition particle (SRP)Jean-Benoit Arlet, Dalia Dimitri, Christian Pagnoux, et al.
Rheumatology (Oxford, England)|September 9, 2021
Bartonella and Coxiella infections presenting as systemic vasculitis: case series and review of literatureMaxime Beydon, Christophe Rodriguez, Alexandre Karras, et al.
Rheumatology (Oxford, England)|October 26, 2021
Rituximab plus methotrexate combination as a salvage therapy in persistently active granulomatosis with polyangiitisBoris Sorin, Maxime Samson, Cécile-Audrey Durel, et al.
Clinical Immunology (Orlando, Fla.)|June 9, 2004
IgG reactivity with a 100-kDa tissue and endothelial cell antigen identified as topoisomerase 1 distinguishes between limited and diffuse systemic sclerosis patientsPaloma García de la Peña-Lefebvre, Youri Chanseaud, Mathieu C Tamby, et al.
Trials|March 19, 2013
Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trialMichael Walsh, Peter A Merkel, Chen Au Peh, et al.
Nature|July 29, 2011
Second messenger role for Mg2+ revealed by human T-cell immunodeficiencyFeng-Yen Li, Benjamin Chaigne-Delalande, Chrysi Kanellopoulou, et al.
Pageof 47